Detalles de la búsqueda
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med;
389(6): 504-513, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379158
2.
Synergy between imputed genetic pathway and clinical information for predicting recurrence in early stage non-small cell lung cancer.
J Biomed Inform;
144: 104424, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352900
3.
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
BMC Cancer;
22(1): 732, 2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790916
4.
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
BMC Cancer;
21(1): 977, 2021 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465283
5.
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.
Eur J Cancer Care (Engl);
28(6): e13164, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571304
6.
Selumetinib in the treatment of non-small-cell lung cancer.
Future Oncol;
12(22): 2545-2560, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467210
7.
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab.
Oncol Ther;
12(1): 175-182, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280181
8.
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
J Clin Oncol;
42(12): 1350-1356, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38324744
9.
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
Lung Cancer (Auckl);
15: 55-67, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741920
10.
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry.
Lung Cancer;
190: 107513, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38432027
11.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol;
13(3): 239-46, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285168
12.
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.
J Clin Med;
12(15)2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568465
13.
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
JCO Precis Oncol;
7: e2200546, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36862967
14.
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC.
JTO Clin Res Rep;
4(2): 100461, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36718142
15.
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Transl Lung Cancer Res;
12(10): 2113-2128, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025806
16.
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Clin Lung Cancer;
23(3): e243-e246, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393061
17.
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
Oncol Ther;
10(1): 167-184, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032007
18.
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial.
J Thorac Oncol;
17(12): 1415-1427, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961520
19.
Integration of Clinical Information and Imputed Aneuploidy Scores to Enhance Relapse Prediction in Early Stage Lung Cancer Patients.
AMIA Annu Symp Proc;
2022: 1062-1071, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128408
20.
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.
J Immunother Cancer;
10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36171009